Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities

Molecular and Cellular Biology

Volumn 28, Issue 6, 2008, Pages 2091-2101

  O'Rourke, John P ^a,b   Ness, Scott A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN C MYB;

ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; EXON; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; POLYSOME; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REGULATORY MECHANISM; RNA TRANSCRIPTION;

ACUTE DISEASE; ADENOCARCINOMA; ADULT; ALTERNATIVE SPLICING; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHILD; EXONS; FEMALE; GENES, MYB; HEMATOPOIETIC STEM CELLS; HUMANS; JURKAT CELLS; K562 CELLS; LEUKEMIA; NEOPLASM PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MYB; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 40349098061     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01870-07     Document Type: Article

References (42)

1. Badiani, P. A., D. Kioussis, D. M. Swirsky, I. A. Lampert, and K. Weston. 1996. T-cell lymphomas in v-Myb transgenic mice. Oncogene 13:2205-2212.
2. Bellon, T., D. Perrotti, and B. Calabretta. 1997. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter. Blood 90:1828-1839.
3. Bender, T. P., C. S. Kremer, M. Kraus, T. Buch, and K. Rajewsky. 2004. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat. Immunol. 5:721-729.
4. Clappier, E., W. Cuccuini, A. Kalota, A. Crinquette, J. M. Cayuela, W. A. Dik, A. W. Langerak, B. Montpellier, B. Nadel, P. Walrafen, O. Delattre, A. Aurias, T. Leblanc, H. Dombret, A. M. Gewirtz, A. Baruchel, F. Sigaux, and J. Soulier. 2007. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 110:1251-1261.
5. Close, J., L. Game, B. Clark, J. Bergounioux, A. Gerovassili, and S. L. Thein. 2004. Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genomics 5:33.
6. Dao, M. A., and J. A. Nolta. 2007. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood 109:2373-2379.
7. Dasgupta, P., and E. P. Reddy. 1989. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences. Oncogene 4:1419-1423.
8. Dash, A. B., F. C. Orrico, and S. A. Ness. 1996. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev. 10:1858-1869.
9. del Prete, M. J., R. Vernal, H. Dolznig, E. W. Mullner, and J. A. Garcia-Sanz. 2007. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 13:414-421.
10. Ghigna, C., S. Giordano, H. Shen, F. Benvenuto, F. Castiglioni, P. M. Comoglio, M. R. Green, S. Riva, and G. Biamonti. 2005. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol. Cell 20:881-890.
11. Introna, M., J. Golay, J. Frampton, T. Nakano, S. A. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63:1289-1297.
12. Johnson, J. M., J. Castle, P. Garrett-Engele, Z. Kan, P. M. Loerch, C. D. Armour, R. Santos, E. E. Schadt, R. Stoughton, and D. D. Shoemaker. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-2144.
13. Karni, R., E. de Stanchina, S. W. Lowe, R. Sinha, D. Mu, and A. R. Krainer. 2007. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14:185-193.
14. Komor, M., S. Guller, C. D. Baldus, S. de Vos, D. Hoelzer, O. G. Ottmann, and W. K. Hofmann. 2005. Transcriptional profiling of human hematopoiesis during in vitro lineage-specific differentiation. Stem Cells 23:1154-1169.
15. Kumar, A., S. J. Baker, C. M. Lee, and E. P. Reddy. 2003. Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb. Mol. Cell. Biol. 23:6631-6645.
16. Lahortiga, I., K. De Keersmaecker, P. Van Vlierberghe, C. Graux, B. Cauwelier, F. Lambert, N. Mentens, H. B. Beverloo, R. Pieters, F. Speleman, M. D. Odero, M. Bauters, G. Froyen, P. Marynen, P. Vandenberghe, I. Wlodarska, J. P. Meijerink, and J. Cools. 2007. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat. Genet. 39:593-595.
17. Lei, W., F. Liu, and S. A. Ness. 2005. Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1. Blood 105:3855-3861.
18. Lei, W., J. J. Rushton, L. M. Davis, F. Liu, and S. A. Ness. 2004. Positive and negative determinants of target gene specificity in myb transcription factors. J. Biol. Chem. 279:29519-29527.
19. Leverson, J. D., and S. A. Ness. 1998. Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol. Cell 1:203-211.
20. Liu, F., W. Lei, J. P. O'Rourke, and S. A. Ness. 2006. Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb. Oncogene 25:795-805.
21. -ΔΔCT method. Methods 25:402-408.
22. Luo, J., Z. L. Deng, X. Luo, N. Tang, W. X. Song, J. Chen, K. A. Sharif, H. H. Luu, R. C. Haydon, K. W. Kinzler, B. Vogelstein, and T. C. He. 2007. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2:1236-1247.
23. Mucenski, M. L., K. McLain, A. B. Kier, S. H. Swerdlow, C. M. Schreiner, T. A. Miller, D. W. Pietryga, W. J. J. Scott, and S. S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677-689.
24. Mukhopadhyaya, R., and L. Wolff. 1992. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J. Virol. 66:6035-6044.
25. Ness, S. A. 1996. The Myb oncoprotein: regulating a regulator. Biochim. Biophys. Acta 1288:F123-F139.
26. Ness, S. A. 1999. Myb binding proteins: regulators and cohorts in transformation. Oncogene 18:3039-3046.
27. Ness, S. A. 2003. Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol. Dis. 31:192-200.
28. Ness, S. A., E. Kowenz-Leutz, T. Casini, T. Graf, and A. Leutz. 1993. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev. 7:749-759.
29. Ness, S. A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59:1115-1125.
30. Rushton, J. J., L. M. Davis, W. Lei, X. Mo, A. Leutz, and S. A. Ness. 2003. Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22:308-313.
31. Rushton, J. J., and S. A. Ness. 2001. The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors. Blood Cells Mol. Dis. 27:459-463.
32. Schuur, E. R., P. Dasgupta, E. P. Reddy, J. M. Rabinovich, and M. A. Baluda. 1993. Alternative splicing of the chicken c-myb exon 9A. Oncogene 8:1839-1847.
33. Schuur, E. R., J. M. Rabinovich, and M. A. Baluda. 1994. Distribution of alternatively spliced chicken c-myb exon 9A among hematopoietic tissues. Oncogene 9:3363-3365.
34. Shen-Ong, G. L., R. M. Skurla, Jr., J. D. Owens, and J. F. Mushinski. 1990. Alternative splicing of RNAs transcribed from the human c-myb gene. Mol. Cell. Biol. 10:2715-2722.
35. Srebrow, A., and A. R. Kornblihtt. 2006. The connection between splicing and cancer. J. Cell Sci. 119:2635-2641.
36. Tanaka, Y., N. P. Patestos, T. Maekawa, and S. Ishii. 1999. B-myb is required for inner cell mass formation at an early stage of development. J. Biol. Chem. 274:28067-28070.
37. Toscani, A., R. V. Mettus, R. Coupland, H. Simpkins, J. Litvin, J. Orth, K. S. Hatton, and E. P. Reddy. 1997. Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature 386:713-717.
38. Tschan, M. P., K. M. Fischer, V. S. Fung, F. Pirnia, M. M. Borner, M. F. Fey, A. Tobler, and B. E. Torbett. 2003. Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J. Biol. Chem. 278:42750-42760.
39. Venables, J. P. 2004. Aberrant and alternative splicing in cancer. Cancer Res. 64:7647-7654.
40. Westin, E. H., K. M. Gorse, and M. F. Clarke. 1990. Alternative splicing of the human c-myb gene. Oncogene 5:1117-1124.
41. Wolff, L., R. Koller, J. Bies, V. Nazarov, B. Hoffman, A. Amanullah, M. Krall, and B. Mock. 1996. Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1. Curr. Top. Microbiol. Immunol. 211:191-199.
42. Woo, C. H., L. Sopchak, and J. S. Lipsick. 1998. Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts. J. Virol. 72:6813-6821.